Advertisement Pharmaceutical Business review - Page 1008 of 5292 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 29, 2026

AstraZeneca to invest $2bn in Summit for ADC combination therapies

AstraZeneca has agreed to invest $2bn in newly issued equity in Summit Therapeutics to develop combination therapies using the bispecific antibody ivonescimab and antibody-drug conjugates (ADCs) across multiple tumour types.

Continue
AstraZeneca and Summit agreed to a clinical collaboration to assess ivonescimab in combination with sonesitatug vedotin. Credit: Jose Eduardo Rubio / Shutterstock.com.
September 29, 2026

Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma

Tolerance Bio plans Phase II clinical development of TLB-33 for thymic preservation, immune resilience. Credit: PeopleImages / Shutterstock.com.
September 28, 2026

Daiichi Sankyo, MSD withdraw cancer drug application

Ifinatamab deruxtecan was discovered by Daiichi Sankyo. Credit: Pavel Kapysh/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Mirum and Incyte’s Atebrioz approved for FOP in US
  2. Amberstone and Henlius agree to develop solid-tumour T-cell engagers
  3. FDA approves Lilly’s Onswik for type 2 diabetes in adults
  4. Genialis and Inventia to enhance pancreatic cancer treatment testing
  5. Basecamp Research secures $140m for AI-driven therapies

PRESS RELEASES

Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography